Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 682 entries
Sorted by: Best Match Show Resources per page
Lipoprotein (a) concentrations in Mexican Americans and non-hispanic whites: the san antonio heart study

STEM and men

Valdez RA.
GSID: i8Ozs6mz2N4J
…, RA Valdez, BD Mitchell, MP Stem - American journal of …, 1992 - academic.oup.com

… Mexican-American men also have lower cardiovascular mortality (17) and a lower prevalence of myocardial infarction (18) than do non-Hispanic white men. A possible explanation for …

Cite
Haffner, S. M., Gruber, K. K., Morales, P. A., Hazuda, H. P., Valdez, R. A., Mitchell, B. D., & Stem, M. P. (1992). Lipoprotein (a) concentrations in Mexican Americans and non-hispanic whites: the san antonio heart study. American journal of epidemiology, 136(9), 1060-1068.
Haffner, Steven M., et al. "Lipoprotein (a) concentrations in Mexican Americans and non-hispanic whites: the san antonio heart study." American journal of epidemiology 136.9 (1992): 1060-1068.
Copy Download .nbib Format: MLA
A Study of the Extended Lipid Profile including Oxidized LDL, Small Dense LDL, Lipoprotein (a) and Apolipoproteins in the Assessment of Cardiovascular Risk in Hypothyroid Patients.

Journal of clinical and diagnostic research : JCDR

Bansal SK, Yadav R.
PMID: 27504276
J Clin Diagn Res. 2016 Jun;10(6):BC04-8. doi: 10.7860/JCDR/2016/19775.8067. Epub 2016 Jun 01.

INTRODUCTION: Hypothyroidism is one of the most common metabolic disorders associated with dyslipidemia which poses a higher risk of Coronary Artery Disease (CAD) in such patients. Biochemical markers which can pick up the risk promptly are becoming imperative now-a-days...

Cite
Bansal SK, Yadav R. A Study of the Extended Lipid Profile including Oxidized LDL, Small Dense LDL, Lipoprotein (a) and Apolipoproteins in the Assessment of Cardiovascular Risk in Hypothyroid Patients. J Clin Diagn Res. 2016;10(6):BC04-8doi: 10.7860/JCDR/2016/19775.8067.
Bansal, S. K., & Yadav, R. (2016). A Study of the Extended Lipid Profile including Oxidized LDL, Small Dense LDL, Lipoprotein (a) and Apolipoproteins in the Assessment of Cardiovascular Risk in Hypothyroid Patients. Journal of clinical and diagnostic research : JCDR, 10(6), BC04-8. https://doi.org/10.7860/JCDR/2016/19775.8067
Bansal, Sanjiv Kumar, and Yadav, Rakhee. "A Study of the Extended Lipid Profile including Oxidized LDL, Small Dense LDL, Lipoprotein (a) and Apolipoproteins in the Assessment of Cardiovascular Risk in Hypothyroid Patients." Journal of clinical and diagnostic research : JCDR vol. 10,6 (2016): BC04-8. doi: https://doi.org/10.7860/JCDR/2016/19775.8067
Bansal SK, Yadav R. A Study of the Extended Lipid Profile including Oxidized LDL, Small Dense LDL, Lipoprotein (a) and Apolipoproteins in the Assessment of Cardiovascular Risk in Hypothyroid Patients. J Clin Diagn Res. 2016 Jun;10(6):BC04-8. doi: 10.7860/JCDR/2016/19775.8067. Epub 2016 Jun 01. PMID: 27504276; PMCID: PMC4963636.
Copy Download .nbib Format: NLM
Lipoprotein(a) and apolipoprotein(a) in polycystic ovary syndrome.

Clinical endocrinology

Enkhmaa B, Anuurad E, Zhang W, Abbuthalha A, Kaur P, Visla J, Karakas S, Berglund L.
PMID: 26341109
Clin Endocrinol (Oxf). 2016 Feb;84(2):229-235. doi: 10.1111/cen.12937. Epub 2015 Oct 05.

OBJECTIVE: Levels of lipoprotein(a), Lp(a), an independent risk factor for cardiovascular disease (CVD), are affected by sex hormones. Women with polycystic ovary syndrome (PCOS) have elevated androgen levels and are at increased CVD risk. We investigated the impact of...

Cite
Enkhmaa B, Anuurad E, Zhang W, et al. Lipoprotein(a) and apolipoprotein(a) in polycystic ovary syndrome. Clin Endocrinol (Oxf). 2015;84(2):229-235doi: 10.1111/cen.12937.
Enkhmaa, B., Anuurad, E., Zhang, W., Abbuthalha, A., Kaur, P., Visla, J., Karakas, S., & Berglund, L. (2016). Lipoprotein(a) and apolipoprotein(a) in polycystic ovary syndrome. Clinical endocrinology, 84(2), 229-235. https://doi.org/10.1111/cen.12937
Enkhmaa, Byambaa, et al. "Lipoprotein(a) and apolipoprotein(a) in polycystic ovary syndrome." Clinical endocrinology vol. 84,2 (2016): 229-235. doi: https://doi.org/10.1111/cen.12937
Enkhmaa B, Anuurad E, Zhang W, Abbuthalha A, Kaur P, Visla J, Karakas S, Berglund L. Lipoprotein(a) and apolipoprotein(a) in polycystic ovary syndrome. Clin Endocrinol (Oxf). 2016 Feb;84(2):229-235. doi: 10.1111/cen.12937. Epub 2015 Oct 05. PMID: 26341109; PMCID: PMC4779071.
Copy Download .nbib Format: NLM
Prevalence of Elevated Serum Homocysteine and Serum Lipoprotein 'a' in Women.

Journal of clinical and diagnostic research : JCDR

Sontakke AN, Tilak MA, Dhat VV, More UM, Shinde SA, Phalak P, Deshmukh AD.
PMID: 25478337
J Clin Diagn Res. 2014 Oct;8(10):CC13-5. doi: 10.7860/JCDR/2014/9607.4995. Epub 2014 Oct 20.

BACKGROUND: Recent studies indicate that the risk of coronary artery disease (CAD) in women is no less than that in men and menopausal women are equally vulnerable as men. Studies of recent risk factors like hyperhomocysteinemia and elevation in...

Cite
Sontakke AN, Tilak MA, Dhat VV, et al. Prevalence of Elevated Serum Homocysteine and Serum Lipoprotein 'a' in Women. J Clin Diagn Res. 2014;8(10):CC13-5doi: 10.7860/JCDR/2014/9607.4995.
Sontakke, A. N., Tilak, M. A., Dhat, V. V., More, U. M., Shinde, S. A., Phalak, P., & Deshmukh, A. D. (2014). Prevalence of Elevated Serum Homocysteine and Serum Lipoprotein 'a' in Women. Journal of clinical and diagnostic research : JCDR, 8(10), CC13-5. https://doi.org/10.7860/JCDR/2014/9607.4995
Sontakke, Alka N, et al. "Prevalence of Elevated Serum Homocysteine and Serum Lipoprotein 'a' in Women." Journal of clinical and diagnostic research : JCDR vol. 8,10 (2014): CC13-5. doi: https://doi.org/10.7860/JCDR/2014/9607.4995
Sontakke AN, Tilak MA, Dhat VV, More UM, Shinde SA, Phalak P, Deshmukh AD. Prevalence of Elevated Serum Homocysteine and Serum Lipoprotein 'a' in Women. J Clin Diagn Res. 2014 Oct;8(10):CC13-5. doi: 10.7860/JCDR/2014/9607.4995. Epub 2014 Oct 20. PMID: 25478337; PMCID: PMC4253155.
Copy Download .nbib Format: NLM
The expanding role of lipoprotein apheresis in the treatment of raised lipoprotein(a) in ischaemic heart disease and refractory angina.

Global cardiology science & practice

Khan TZ, Pottle A, Pennell DJ, Barbir MS.
PMID: 25054114
Glob Cardiol Sci Pract. 2014 Jan 29;2014(1):3-12. doi: 10.5339/gcsp.2014.3. eCollection 2014.

It is increasingly recognised that lipoprotein(a) [Lp(a)], an inherited, genetically-determined form of LDL-cholesterol, is an independent cardiovascular risk factor and predictor of adverse cardiovascular outcomes. Lp(a) is felt to increase cardiovascular risk via its pro-thrombotic effect and by enhancing...

Cite
Khan TZ, Pottle A, Pennell DJ, et al. The expanding role of lipoprotein apheresis in the treatment of raised lipoprotein(a) in ischaemic heart disease and refractory angina. Glob Cardiol Sci Pract. 2014;2014(1):3-12doi: 10.5339/gcsp.2014.3.
Khan, T. Z., Pottle, A., Pennell, D. J., & Barbir, M. S. (2014). The expanding role of lipoprotein apheresis in the treatment of raised lipoprotein(a) in ischaemic heart disease and refractory angina. Global cardiology science & practice, 2014(1), 3-12. https://doi.org/10.5339/gcsp.2014.3
Khan, Tina Z, et al. "The expanding role of lipoprotein apheresis in the treatment of raised lipoprotein(a) in ischaemic heart disease and refractory angina." Global cardiology science & practice vol. 2014,1 (2014): 3-12. doi: https://doi.org/10.5339/gcsp.2014.3
Khan TZ, Pottle A, Pennell DJ, Barbir MS. The expanding role of lipoprotein apheresis in the treatment of raised lipoprotein(a) in ischaemic heart disease and refractory angina. Glob Cardiol Sci Pract. 2014 Jan 29;2014(1):3-12. doi: 10.5339/gcsp.2014.3. eCollection 2014. PMID: 25054114; PMCID: PMC4104372.
Copy Download .nbib Format: NLM
Short-term efficacy of recombinant human GH therapy in cured acromegaly patients with GH deficiency: a single-center experience.

Endocrine connections

Dutta P, Mahendran B, Reddy KS, Ahluwalia J, Vaiphei K, Kochhar RK, Gupta P, Srinivasan A, Prakash M, Mukherjee KK, Shah VN, Parthan G, Bhansali A.
PMID: 25600246
Endocr Connect. 2015 Mar;4(1):65-75. doi: 10.1530/EC-14-0132. Epub 2015 Jan 19.

The effectiveness and short-term safety of recombinant human GH (r-hGH) in acromegaly patients with GH deficiency (GHD) after treatment are not well established. The study includes ten subjects with acromegaly who had GHD treated with r-hGH for 6 months....

Cite
Dutta P, Mahendran B, Reddy KS, et al. Short-term efficacy of recombinant human GH therapy in cured acromegaly patients with GH deficiency: a single-center experience. Endocr Connect. 2015;4(1):65-75doi: 10.1530/EC-14-0132.
Dutta, P., Mahendran, B., Reddy, K. S., Ahluwalia, J., Vaiphei, K., Kochhar, R. K., Gupta, P., Srinivasan, A., Prakash, M., Mukherjee, K. K., Shah, V. N., Parthan, G., & Bhansali, A. (2015). Short-term efficacy of recombinant human GH therapy in cured acromegaly patients with GH deficiency: a single-center experience. Endocrine connections, 4(1), 65-75. https://doi.org/10.1530/EC-14-0132
Dutta, Pinaki, et al. "Short-term efficacy of recombinant human GH therapy in cured acromegaly patients with GH deficiency: a single-center experience." Endocrine connections vol. 4,1 (2015): 65-75. doi: https://doi.org/10.1530/EC-14-0132
Dutta P, Mahendran B, Reddy KS, Ahluwalia J, Vaiphei K, Kochhar RK, Gupta P, Srinivasan A, Prakash M, Mukherjee KK, Shah VN, Parthan G, Bhansali A. Short-term efficacy of recombinant human GH therapy in cured acromegaly patients with GH deficiency: a single-center experience. Endocr Connect. 2015 Mar;4(1):65-75. doi: 10.1530/EC-14-0132. Epub 2015 Jan 19. PMID: 25600246; PMCID: PMC4321405.
Copy Download .nbib Format: NLM
Using Mendelian Randomization studies to Assess Causality and Identify New Therapeutic Targets in Cardiovascular Medicine.

Current genetic medicine reports

Zhao W, Lee JJ, Rasheed A, Saleheen D.
PMID: 29082115
Curr Genet Med Rep. 2016 Dec;4(4):207-212. doi: 10.1007/s40142-016-0103-4. Epub 2016 Sep 10.

Integration of knowledge generated from genetic studies on intermediate biomarkers and CHD can provide a reliable approach to help assess causal pathways in coronary heart disease. Mendelian Randomization (MR) studies are a powerful tool to assess causal relevance of...

Cite
Zhao W, Lee JJ, Rasheed A, et al. Using Mendelian Randomization studies to Assess Causality and Identify New Therapeutic Targets in Cardiovascular Medicine. Curr Genet Med Rep. 2016;4(4):207-212doi: 10.1007/s40142-016-0103-4.
Zhao, W., Lee, J. J., Rasheed, A., & Saleheen, D. (2016). Using Mendelian Randomization studies to Assess Causality and Identify New Therapeutic Targets in Cardiovascular Medicine. Current genetic medicine reports, 4(4), 207-212. https://doi.org/10.1007/s40142-016-0103-4
Zhao, Wei, et al. "Using Mendelian Randomization studies to Assess Causality and Identify New Therapeutic Targets in Cardiovascular Medicine." Current genetic medicine reports vol. 4,4 (2016): 207-212. doi: https://doi.org/10.1007/s40142-016-0103-4
Zhao W, Lee JJ, Rasheed A, Saleheen D. Using Mendelian Randomization studies to Assess Causality and Identify New Therapeutic Targets in Cardiovascular Medicine. Curr Genet Med Rep. 2016 Dec;4(4):207-212. doi: 10.1007/s40142-016-0103-4. Epub 2016 Sep 10. PMID: 29082115; PMCID: PMC5658043.
Copy Download .nbib Format: NLM
Therapeutic effects of soluble dietary fiber consumption on type 2 diabetes mellitus.

Experimental and therapeutic medicine

Chen C, Zeng Y, Xu J, Zheng H, Liu J, Fan R, Zhu W, Yuan L, Qin Y, Chen S, Zhou Y, Wu Y, Wan J, Mi M, Wang J.
PMID: 27446349
Exp Ther Med. 2016 Aug;12(2):1232-1242. doi: 10.3892/etm.2016.3377. Epub 2016 May 20.

Soluble dietary fiber (DF) reduces the risk of developing diabetes and may have therapeutic effects in patients with type 2 diabetes mellitus (DM2). The present study aimed to investigate the effect of soluble DF on metabolic control in patients...

Cite
Chen C, Zeng Y, Xu J, et al. Therapeutic effects of soluble dietary fiber consumption on type 2 diabetes mellitus. Exp Ther Med. 2016;12(2):1232-1242doi: 10.3892/etm.2016.3377.
Chen, C., Zeng, Y., Xu, J., Zheng, H., Liu, J., Fan, R., Zhu, W., Yuan, L., Qin, Y., Chen, S., Zhou, Y., Wu, Y., Wan, J., Mi, M., & Wang, J. (2016). Therapeutic effects of soluble dietary fiber consumption on type 2 diabetes mellitus. Experimental and therapeutic medicine, 12(2), 1232-1242. https://doi.org/10.3892/etm.2016.3377
Chen, Chunye, et al. "Therapeutic effects of soluble dietary fiber consumption on type 2 diabetes mellitus." Experimental and therapeutic medicine vol. 12,2 (2016): 1232-1242. doi: https://doi.org/10.3892/etm.2016.3377
Chen C, Zeng Y, Xu J, Zheng H, Liu J, Fan R, Zhu W, Yuan L, Qin Y, Chen S, Zhou Y, Wu Y, Wan J, Mi M, Wang J. Therapeutic effects of soluble dietary fiber consumption on type 2 diabetes mellitus. Exp Ther Med. 2016 Aug;12(2):1232-1242. doi: 10.3892/etm.2016.3377. Epub 2016 May 20. PMID: 27446349; PMCID: PMC4950069.
Copy Download .nbib Format: NLM
Fluorescence labeling and interaction of atherogenic lipoproteins with cultured cells.

Journal of fluorescence

Hofer G, Gorges R, Kostner GM, Paltauf F, Hermetter A.
PMID: 24233606
J Fluoresc. 1994 Dec;4(4):319-21. doi: 10.1007/BF01881447.

We prepared lipoprotein (a) and LDL covalently labeled with either BODIPY or rhodamine. A dual wavelength method was used for the microscopic observation of both lipoproteins during their interaction with HepG2 cells. Since a large proportion of Lp(a) colocalized...

Cite
Hofer G, Gorges R, Kostner GM, et al. Fluorescence labeling and interaction of atherogenic lipoproteins with cultured cells. J Fluoresc. 1994;4(4):319-21doi: 10.1007/BF01881447.
Hofer, G., Gorges, R., Kostner, G. M., Paltauf, F., & Hermetter, A. (1994). Fluorescence labeling and interaction of atherogenic lipoproteins with cultured cells. Journal of fluorescence, 4(4), 319-21. https://doi.org/10.1007/BF01881447
Hofer, G, et al. "Fluorescence labeling and interaction of atherogenic lipoproteins with cultured cells." Journal of fluorescence vol. 4,4 (1994): 319-21. doi: https://doi.org/10.1007/BF01881447
Hofer G, Gorges R, Kostner GM, Paltauf F, Hermetter A. Fluorescence labeling and interaction of atherogenic lipoproteins with cultured cells. J Fluoresc. 1994 Dec;4(4):319-21. doi: 10.1007/BF01881447. PMID: 24233606.
Copy Download .nbib Format: NLM
Acute phase reactant dynamics and incidence of microvascular dysfunctions in type 2 diabetes mellitus.

Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences

Azenabor A, Ogbera AO, Adejumo NE, Adejare AO.
PMID: 22973323
J Res Med Sci. 2011 Oct;16(10):1298-305.

BACKGROUND: Acute Phase Reactants (APRs) have a wide range of activities that contribute to host defense. The aim of this report was to evaluate the dynamics and magnitude of these proteins in various microvascular complications in diabetes mellitus (DM)....

Cite
Azenabor A, Ogbera AO, Adejumo NE, et al. Acute phase reactant dynamics and incidence of microvascular dysfunctions in type 2 diabetes mellitus. J Res Med Sci. 2011;16(10):1298-305
Azenabor, A., Ogbera, A. O., Adejumo, N. E., & Adejare, A. O. (2011). Acute phase reactant dynamics and incidence of microvascular dysfunctions in type 2 diabetes mellitus. Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences, 16(10), 1298-305.
Azenabor, Alfred, et al. "Acute phase reactant dynamics and incidence of microvascular dysfunctions in type 2 diabetes mellitus." Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences vol. 16,10 (2011): 1298-305.
Azenabor A, Ogbera AO, Adejumo NE, Adejare AO. Acute phase reactant dynamics and incidence of microvascular dysfunctions in type 2 diabetes mellitus. J Res Med Sci. 2011 Oct;16(10):1298-305. PMID: 22973323; PMCID: PMC3430019.
Copy Download .nbib Format: NLM
Hypoascorbemia induces atherosclerosis and vascular deposition of lipoprotein(a) in transgenic mice.

American journal of cardiovascular disease

Cha J, Niedzwiecki A, Rath M.
PMID: 26064792
Am J Cardiovasc Dis. 2015 Mar 20;5(1):53-62. eCollection 2015.

Lipoprotein(a), a variant of LDL carrying the adhesive glycoprotein apo(a), is a leading risk factor for cardiovascular disease. Lipoprotein(a) (Lp(a)) is found in humans and subhuman primates but rarely in lower mammals. Better understanding of the evolutionary advantage of...

Cite
Cha J, Niedzwiecki A, Rath M. Hypoascorbemia induces atherosclerosis and vascular deposition of lipoprotein(a) in transgenic mice. Am J Cardiovasc Dis. 2015;5(1):53-62
Cha, J., Niedzwiecki, A., & Rath, M. (2015). Hypoascorbemia induces atherosclerosis and vascular deposition of lipoprotein(a) in transgenic mice. American journal of cardiovascular disease, 5(1), 53-62.
Cha, John, et al. "Hypoascorbemia induces atherosclerosis and vascular deposition of lipoprotein(a) in transgenic mice." American journal of cardiovascular disease vol. 5,1 (2015): 53-62.
Cha J, Niedzwiecki A, Rath M. Hypoascorbemia induces atherosclerosis and vascular deposition of lipoprotein(a) in transgenic mice. Am J Cardiovasc Dis. 2015 Mar 20;5(1):53-62. eCollection 2015. PMID: 26064792; PMCID: PMC4447075.
Copy Download .nbib Format: NLM
Serum lipid profile spectrum and delayed cerebral ischemia following subarachnoid hemorrhage: Is there a relation?.

Surgical neurology international

Dhandapani S, Aggarwal A, Srinivasan A, Meena R, Gaudihalli S, Singh H, Dhandapani M, Mukherjee KK, Gupta SK.
PMID: 26664869
Surg Neurol Int. 2015 Oct 23;6:S543-8. doi: 10.4103/2152-7806.168067. eCollection 2015.

BACKGROUND: Serum lipid abnormalities are known to be important risk factors for vascular disorders. However, their role in delayed cerebral ischemia (DCI), the major cause of morbidity after subarachnoid hemorrhage (SAH) remains unclear. This study was an attempt to...

Cite
Dhandapani S, Aggarwal A, Srinivasan A, et al. Serum lipid profile spectrum and delayed cerebral ischemia following subarachnoid hemorrhage: Is there a relation?. Surg Neurol Int. 2015;6:S543-8doi: 10.4103/2152-7806.168067.
Dhandapani, S., Aggarwal, A., Srinivasan, A., Meena, R., Gaudihalli, S., Singh, H., Dhandapani, M., Mukherjee, K. K., & Gupta, S. K. (2015). Serum lipid profile spectrum and delayed cerebral ischemia following subarachnoid hemorrhage: Is there a relation?. Surgical neurology international, 6S543-8. https://doi.org/10.4103/2152-7806.168067
Dhandapani, Sivashanmugam, et al. "Serum lipid profile spectrum and delayed cerebral ischemia following subarachnoid hemorrhage: Is there a relation?." Surgical neurology international vol. 6 (2015): S543-8. doi: https://doi.org/10.4103/2152-7806.168067
Dhandapani S, Aggarwal A, Srinivasan A, Meena R, Gaudihalli S, Singh H, Dhandapani M, Mukherjee KK, Gupta SK. Serum lipid profile spectrum and delayed cerebral ischemia following subarachnoid hemorrhage: Is there a relation?. Surg Neurol Int. 2015 Oct 23;6:S543-8. doi: 10.4103/2152-7806.168067. eCollection 2015. PMID: 26664869; PMCID: PMC4653325.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 682 entries